Congress Asset Management’s Tango Therapeutics TNGX Stock Holding History
Bought
Maintained
Sold
Other funds holding TNGX
Congress Asset Management's TNGX Position: Q3 2026 in Review
Congress Asset Management increased its Tango Therapeutics (TNGX) stake by 26% in Q3 2026, buying an estimated $2.54M and bringing the position to 478,454 shares worth $11.9M. The position accounts for 0.08% of the portfolio, ranked #207.
Congress Asset Management first reported a position in TNGX in Q2 2024 and has held it in 10 quarters since. 3 funds tracked by Wall St. Rank hold TNGX as of Q3 2026.
- Congress Asset Management held 478,454 shares of Tango Therapeutics worth $11.9M as of Q3 2026.
- Congress Asset Management bought 97,708 Tango Therapeutics shares in Q3 2026, an estimated $2.54M.
- Tango Therapeutics made up 0.08% of Congress Asset Management's portfolio in Q3 2026, its #207 holding.
- Congress Asset Management first reported a position in Tango Therapeutics in Q2 2024 and has held it in 10 quarters since.
- 3 funds tracked by Wall St. Rank held Tango Therapeutics as of Q3 2026.
Based on Congress Asset Management's 13F filing for Q3 2026, filed 6 Oct 2026.